Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux
Authors: E. Hohenstein1; D. Tsakiris2; A. J. Bircher1
Source: Contact Dermatitis, Volume 51, Number 3, September 2004 , pp. 149-151(3)
Publisher: Blackwell Publishing
Keywords: anticoagulation; cutaneous adverse drug reaction; delayed-type hypersensitivity; fondaparinux; heparin; pentasaccharide; therapeutic alternatives
Document Type: Research article
DOI: 10.1111/j.0105-1873.2004.0426c.x
Affiliations: 1: Allergy Unit, Department of Dermatology, and 2: Division of Hematology, University Hospital, Basel CH-4031, Switzerland

Click here for Page Help